A multiparameter classifier to predict response to lapatinib plus trastuzumab (LT) without chemotherapy in HER2+ breast cancer (BC) Meeting Abstract


Authors: Veeraraghavan, J.; Gutierrez, C.; De Angelis, C.; Wang, T.; Pascual, T.; Weigelt, B.; Galvan, P.; Rexer, B. N.; Forero-Torres, A.; Wolff, A. C.; Nanda, R.; Storniolo, A. M.; Krop, I. E.; Goetz, M. P.; Reis-Filho, J. S.; Hilsenbeck, S. G.; Prat, A.; Osborne, C. K.; Schiff, R.; Rimawi, M. F.
Abstract Title: A multiparameter classifier to predict response to lapatinib plus trastuzumab (LT) without chemotherapy in HER2+ breast cancer (BC)
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual Conference
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Language: English
ACCESSION: WOS:000560368300185
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.1011
Notes: Meeting Abstract: 1011 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Britta Weigelt
    632 Weigelt